Journal of the American Academy of Dermatology
Volume 51, Issue 6 , Pages 910-918 , December 2004

Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin

  • Maritza A. Middelkamp-Hup, MD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • ,
  • Madhu A. Pathak, PhD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • ,
  • Concepcion Parrado, MD, PhD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • Department of Morphological Sciences, Faculty of Medicine, Malaga University
    • ,
  • David Goukassian, MD

      Affiliations

    • Department of Dermatology, Boston University Medical School
    • ,
  • Francisca Rius-Díaz, PhD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • Department of Morphological Sciences, Faculty of Medicine, Malaga University
    • ,
  • Martín C. Mihm, MD

      Affiliations

    • Department of Pathology (Dermatopathology), Massachusetts General Hospital, Harvard Medical School
    • ,
  • Thomas B. Fitzpatrick, MD, PhD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • ,
  • Salvador González, MD, PhD

      Affiliations

    • From the Wellman Laboratories of Photomedicine, Department of Dermatology
    • Corresponding Author InformationReprint requests: Salvador González, Md, PhD, Wellman Laboratories of Photomedicine, BHX 630, Massachusetts General Hospital, Boston, MA 02114.

,Accepted 23 June 2004.

References 

  1. Walker SL, Hawk JLM, Young AR. Acute and chronic effects of ultraviolet radiation on the skin. In:  Freedberg IM,  Eisen AZ,  Wolff K,  Austen KF,  Goldsmith LA,  Katz SI editor. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill Companies Inc; 2003;p. 1275–1282
  2. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, et al. UV-induced skin damage. Toxicology. 2003;189:21–39
  3. Diffey B. Sunscreen isn't enough. J Photochem Photobiol B. 2001;64:105–108
  4. Stahl W, Heinrich U, Jungmann H, Sies H, Tronnier H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr. 2000;71:795–798
  5. Stahl W, Sies H. Carotenoids and protection against solar UV radiation. Skin Pharmacol Appl Skin Physiol. 2002;15:291–296
  6. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol. 1998;38:45–48
  7. Mireles-Rocha H, Galindo I, Huerta M, Trujillo-Hernandez B, Elizalde A, Cortes-Franco R. UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose. Acta Derm Venereol. 2002;82:21–24
  8. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med. 1998;25:1006–1012
  9. Mathews-Roth MM, Pathak MA, Parrish J, Fitzpatrick TB, Kass EH, Toda K, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol. 1972;59:349–353
  10. Garmyn M, Ribaya-Mercado JD, Russel RM, Bhawan J, Gilchrest BA. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol. 1995;4:104–111
  11. Wolf C, Steiner A, Honigsmann H. Do oral carotenoids protect human skin against ultraviolet erythema, psoralen phototoxicity, and ultraviolet-induced DNA damage?. J Invest Dermatol. 1988;90:55–57
  12. McArdle F, Rhodes LE, Parslew R, Jack CI, Friedmann PS, Jackson MJ. UVR-induced oxidative stress in human skin in vivo: effects of oral vitamin C supplementation. Free Radic Biol Med. 2002;33:1355–1362
  13. Werninghaus K, Meydani M, Bhawan J, Margolis R, Blumberg JB, Gilchrest BA. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 1994;130:1257–1261
  14. Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection. [review] Int J Oncol. 2001;18:1307–1313
  15. Horvath A, Alvarado F, Szocs J, de Alvardo ZN, Padilla G. Metabolic effects of calagualine, an antitumoral saponine of Polypodium leucotomos. Nature. 1967;214:1256–1258
  16. Gomes AJ, Lunardi CN, Gonzalez S, Tedesco AC. The antioxidant action of Polypodium leucotomos extract and kojic acid: reactions with reactive oxygen species. Braz J Med Biol Res. 2001;34:1487–1494
  17. Gonzalez S, Pathak MA. Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomos. Photodermatol Photoimmunol Photomed. 1996;12:45–56
  18. Gonzalez S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB. Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed. 1997;13:50–60
  19. Middelkamp-Hup MA, Pathak MA, Parrado C, Garcia-Caballero T, Rius-Díaz F, Fitzpatrick TB, et al. Orally administered Polypodium leucotomos extract decreases PUVA-induced phototoxicity, pigmentation and damage of human skin. J Am Acad Dermatol. 2004;50:41–49
  20. Krenacs L, Tiszalvics L, Krenacs T, Boumsell L. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol. 1993;171:99–104
  21. Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest. 1993;68:629–636
  22. Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37:1509–1515
  23. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens—evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7:82–90
  24. Kane KS, Maytin EV. Ultraviolet B-induced apoptosis of keratinocytes in murine skin is reduced by mild local hyperthermia. J Invest Dermatol. 1995;104:62–67
  25. Massi D, Franchi A, Borgognoni L, Paglierani M, Reali M, Santucci M. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma: a quantitative morphologic analysis. Virchows Arch. 2002;440:22–28
  26. Brieva A, Guerrero A, Pivel JP. Immunomodulatory properties of a hydrophilic extract of Polypodium leucotomos. Inflammopharmacol. 2002;9:361–371
  27. Gonzalez S, Alcaraz MV, Cuevas J, Perez M, Jaen P, Alvarez-Mon M, et al. An extract of the fern Polypodium leucotomos (Difur) modulates Th1/Th2 cytokines balance in vitro and appears to exhibit anti-angiogenic activities in vivo: pathogenic relationships and therapeutic implications. Anticancer Res. 2000;20:1567–1575
  28. Rayward J, Villarrubia VG, Guillen C, Prieto A, Rodriguez-Zapata M, Sada G, et al. An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitro. Int J Immunopharmacol. 1997;19:9–14
  29. Alcaraz MV, Pathak MA, Rius F, Kollias N, Gonzalez S. An extract of Polypodium leucotomos appears to minimize certain photoaging changes in a hairless albino mouse animal model: a pilot study. Photodermatol Photoimmunol Photomed. 1999;15:120–126
  30. Jimenez D, Naranjo R, Doblare E, Munoz C, Vargas JF. Anapsos, an anti-psoriatic drug, in atopic dermatitis. Allergol Immunopathol (Madr). 1987;15:185–189
  31. Mohammad A. Vitiligo repigmentation with Anapsos (Polypodium leucotomos). Int J Dermatol. 1989;28:479
  32. Padilla HC, Lainez H, Pacheco JA. A new agent (hydrophilic fraction of Polypodium leucotomos) for management of psoriasis. Int J Dermatol. 1974;13:276–282
  33. Capella-Pérez MC, Castell-Rodellas A. Double blind study of Polypodium leucotomos (120 mg/kg) in the treatment of psoriasis. Actas Dermosifilogr. 1981;72:187–194
  34. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol. 1995;32:53–62
  35. Steenvoorden DP, van Henegouwen GM. The use of endogenous antioxidants to improve photoprotection. J Photochem Photobiol B. 1997;41:1–10
  36. Biesalski HK, Hemmes C, Hopfenmuller W, Schmid C, Gollnick HP. Effects of controlled exposure of sunlight on plasma and skin levels of beta-carotene. Free Radic Res. 1996;24:215–224
  37. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial; nutritional prevention of cancer study group. JAMA. 1996;276:1957–1963
  38. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139:451–455
  39. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin: the skin cancer prevention study group. N Engl J Med. 1990;323:789–795
  40. Einspahr JG, Stratton SP, Bowden GT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol. 2002;41:269–285
  41. Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial; southwest skin cancer prevention study group. Cancer Epidemiol Biomarkers Prev. 1997;6:949–956
  42. Cartmel B, Moon TE, Levine N. Effects of long-term intake of retinol on selected clinical and laboratory indexes. Am J Clin Nutr. 1999;69:937–943
  43. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318:1633–1637
  44. Hart RW, Setlow RB, Woodhead AD. Evidence that pyrimidine dimers in DNA can give rise to tumors. Proc Natl Acad Sci U S A. 1977;74:5574–5578
  45. Vink AA, Roza L. Biological consequences of cyclobutane pyrimidine dimers. J Photochem Photobiol B. 2001;65:101–104
  46. Doshi R, Preston BD. Effect of oxidative exonuclease damage on the fidelity of T7 DNA polymerase. Proc Am Assoc Cancer Res. 1990;31:100
  47. Chen W, Barthelman M, Martinez J, Alberts D, Gensler HL. Inhibition of cyclobutane pyrimidine dimer formation in epidermal p53 gene of UV-irradiated mice by alpha-tocopherol. Nutr Cancer. 1997;29:205–211
  48. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. DNA repair. In:  Alberts B,  Bray D,  Lewis J,  Raff M,  Roberts K,  Watson JD editor. Molecular biology of the cell. New York: Garland Publishing Inc; 1994;p. 242–251
  49. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study; xeroderma pigmentosum study group. Lancet. 2001;357:926–929
  50. Godar DE. Light and death: photons and apoptosis. J Investig Dermatol Symp Proc. 1999;4:17–23
  51. Gollnick HPM, Hopfenmuller W, Hemmes C, Chun SC, Schmid C, Sundermeier K, et al. Systemic beta carotene plus topical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlight: results of the Berlin-Eilath study. Eur J Dermatol. 1996;6:200–205
  52. Cavanagh LL, Sluyter R, Henderson KG, Barnetson RS, Halliday GM. Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumor. Immunology. 1996;87:475–480
  53. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD. Tumor antigen presentation by murine epidermal cells. J Immunol. 1991;146:3656–3661
  54. Wattenberg LW. An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med. 1997;216:133–141
  55. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033–1079
  56. Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med. 1998;187:2045–2053
  57. Gonzalez S, Moran M, Kochevar IE. Chronic photodamage in skin of mast cell-deficient mice. Photochem Photobiol. 1999;70:248–253

 Dr González presently holds a joint appointment at the Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York.Supported by a research grant from Industrial Farmaceutica Cantabria, SA, Madrid, Spain.Conflicts of interest: None identified.Presented in part at the 20th World Congress of Dermatology, Paris, France, July 1-5, 2002.

PII: S0190-9622(04)01714-1

doi: 10.1016/j.jaad.2004.06.027

Journal of the American Academy of Dermatology
Volume 51, Issue 6 , Pages 910-918 , December 2004

Article Tools

* Image Usage & Resolution